Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease

Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation

NCT02172521 ·Status: COMPLETED

Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02172482 ·Status: COMPLETED

BI 1744 CL in Patients With Severe Renal Impairment in Comparison to Subjects With Normal Renal Function

NCT02172118 ·Status: COMPLETED ·Phase: PHASE1

Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)

NCT00274027 ·Status: COMPLETED ·Phase: PHASE3

Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD

NCT00274053 ·Status: COMPLETED ·Phase: PHASE3

Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)

NCT01857323 ·Status: COMPLETED ·Phase: PHASE3

Effects of Spiolto® Respimat® (Tiotropium/Olodaterol) on Cardiac Function in Hyperinflated COPD Subjects

NCT04231214 ·Status: COMPLETED ·Phase: PHASE4

Tiotropium (Spiriva) Rehabilitation Study

NCT00274521 ·Status: COMPLETED ·Phase: PHASE3

Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema

NCT00570544 ·Status: COMPLETED

Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®

NCT01696058 ·Status: COMPLETED ·Phase: PHASE3

Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment.

NCT02172547 ·Status: COMPLETED

Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT03118765 ·Status: COMPLETED ·Phase: PHASE2

Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva

NCT00274066 ·Status: COMPLETED ·Phase: PHASE3

12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD

NCT00240435 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics of the Fixed Dose Combination of Tiotropium Plus BI 54903 Versus the Combination of the Monoproducts of Tiotropium and BI 54903 in Healthy Volunteers

NCT01309139 ·Status: COMPLETED ·Phase: PHASE1

A Randomised, Double-blind, Crossover Study of Ba679BR Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00292448 ·Status: COMPLETED ·Phase: PHASE2

Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®

NCT01694771 ·Status: COMPLETED ·Phase: PHASE3

Drug Use Survey of RESPIMAT in Patients With COPD

NCT01145053 ·Status: COMPLETED

Safety, Tolerability and Pharmacokinetics of the Fixed Dose Combination of BI 1744 CL Plus BI 54903 XX Via Respimat® B Versus the Free Combination of BI 1744 CL Via Respimat® A and BI 54903 XX Via Respimat® B in Healthy Male and Female Volunteers

NCT02220660 ·Status: COMPLETED ·Phase: PHASE1

Preference Tiotropium Respimat Study in COPD

NCT01810692 ·Status: COMPLETED

Airway Effects of Tiotropium in Patients With COPD

NCT02683668 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses of BI 1744 CL in Healthy Male and Female Volunteers

NCT02171780 ·Status: COMPLETED ·Phase: PHASE1

The Effects of Tiotropium on the Cough Reflex in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00870896 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD)

NCT00281567 ·Status: COMPLETED ·Phase: PHASE3

Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients

NCT00274508 ·Status: COMPLETED ·Phase: PHASE3